SG Americas Securities’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-600,000
Closed -$5K 3406
2025
Q1
$5K Sell
600,000
-15,000
-2% -$595K ﹤0.01% 3424
2024
Q4
$252K Buy
615,000
+315,000
+105% +$14.1M ﹤0.01% 1941
2024
Q3
$133K Hold
300,000
﹤0.01% 2830
2024
Q2
$17K Hold
300,000
﹤0.01% 2766
2024
Q1
$1.33M Buy
300,000
+239,000
+392% +$7.25M 0.01% 1028
2023
Q4
$37K Sell
61,000
-91,500
-60% -$3.36M ﹤0.01% 2965
2023
Q3
$113K Buy
152,500
+82,400
+118% +$4.99M ﹤0.01% 2710
2023
Q2
$1.18M Hold
70,100
0.01% 973
2023
Q1
$442K Buy
+70,100
New +$3.87M 0.01% 1810

Other funds holding OMCL

SG Americas Securities's OMCL Position: Q1 2026 in Review

SG Americas Securities reduced its Omnicell (OMCL) stake by 33% in Q1 2026, selling an estimated $285K and leaving 13,731 shares worth $458K. The position accounts for ﹤0.01% of the portfolio, ranked #2229.

SG Americas Securities first reported a position in OMCL in Q3 2013 and has held it in 36 quarters since. The position peaked at $55.2M in Q3 2021. 272 funds tracked by Wall St. Rank hold OMCL as of Q1 2026.

  • SG Americas Securities held 13,731 shares of Omnicell worth $458K as of Q1 2026.
  • SG Americas Securities sold 6,816 Omnicell shares in Q1 2026, an estimated $285K.
  • Omnicell made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #2229 holding.
  • SG Americas Securities first reported a position in Omnicell in Q3 2013 and has held it in 36 quarters since.
  • SG Americas Securities's Omnicell position peaked at $55.2M in Q3 2021.
  • 272 funds tracked by Wall St. Rank held Omnicell as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.